ProBiotix Health, a life sciences company developing pioneering probiotic solutions for cardiometabolic and women’s health, has announced it will launch an instant melt formulation for YourBiotixMH at this year’s Vitafoods Europe tradeshow.
Designed specifically for women during or after menopause, the revolutionary delivery format ensures the probiotic melts instantly on the tongue without any water, making it convenient to take anywhere and at any time. Delegates will be available to try the new peach flavoured format at the company’s exhibition stand, 4K55, between 5th and 7th May at the Fira Barcelona Gran Via, Barcelona, Spain.
By 2030, it is estimated that 1.2 billion women globally will be either transitioning to the menopause. For women in this critical life-changing period, there is also rising awareness of cardiovascular risk and a growing consumer demand for clinically substantiated ingredients that offer a protective and preventative function to contribute to long-term wellness.
“Menopause reflects a critical turning point in women’s cardiometabolic health. Research has highlighted that post-menopausal women are five times more likely to suffer a heart attack, while 77% of women aged 45 and over have raised cholesterol,” comments Cellan Davies, Head of Marketing, at ProBiotix. “With the shift from reactive symptom management to preventative health outcomes, this has created a growing unmet need for solutions that go beyond symptom relief, such as hot flushes and night sweats, and address long-term cardiometabolic health. ProBiotix is uniquely positioned to meet this need by developing precision probiotic solutions, which are backed by clinical substantiation, that focus on long-term health support.
“With YourBiotixMH Instant Melt, the solution harnesses the power of our clinically validated probiotic strain LPLDL® (Lactobacillus Plantarum), in combination with selected nutrients that support positive menopause outcomes, such as Isoflavones, Thiamine, and vitamins D and B6.”
Independent human intervention studies carried out by the University of Reading and University of Roehampton have validated LPLDL‘s positive outcomes for cardiometabolic health. Results have indicated that LPLDL significantly reduces total cholesterol by up to 37%, LDL by 36%, decreases Apolipoprotein B by 28% and blood pressure by 5%.
Cellan continued: “As oestrogen plays such a protective role in maintaining healthy cholesterol levels, vascular function and arterial health, these cardiometabolic health markers are crucially important to menopausal and postmenopausal women who face declining oestrogen levels throughout this challenging transitional period, impacting heart health, bone density, energy and mood. This can have a major impact on the workplace, disrupting women’s careers and economic productivity.
“With better science, care and support, women no longer need to suffer with these symptoms in silence. It is why YourBiotixMH was specifically developed to both relieve the symptoms and address long-term cardiovascular and bone health risks that accompany menopause, so that women can add life to years, not just years to life.”
With tighter regulations now coming into force for the life sciences industry, including the EU monacolin ban this year regarding its pharmacological activity and potential safety risks, Cellan concludes:
“Many organisations are now seeking solutions that align with future regulatory and safety expectations due to evolving scrutiny around certain cholesterol-lowering ingredients, such as Monacolin K. For nutraceutical developers, this is our period of rapid reformulation. It is causing the industry to revisit ingredient selection and reconsider other formulation opportunities that perhaps were not possible before. This is driving forward momentum of scientifically validated alternatives and new approaches to cardiometabolic health.”
For further information on YourBiotixMH and to try out the new Instant Melt format, or to understand how brands ProBiotix Health partner with are responding to current regulatory pressure, contact the team to arrange a meeting at Vitafoods Europe, taking place at the Fira Barcelona Gran Via, Barcelona, Spain, between 5-7th May 2026: https://probiotixhealth.com/contact-us/
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
